Determination of the binding mechanism of histone deacetylase inhibitors
This article places its focus on methods and tools enabling the elucidation of the mechanism by which ligands, small‐molecule inhibitors, or substrates interact with zinc‐containing bacterial or human members of the histone deacetylase family (HDACs). These methods include biochemical and biophysica...
Gespeichert in:
Veröffentlicht in: | Chemical biology & drug design 2019-06, Vol.93 (6), p.1214-1250 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1250 |
---|---|
container_issue | 6 |
container_start_page | 1214 |
container_title | Chemical biology & drug design |
container_volume | 93 |
creator | Meyer‐Almes, Franz‐Josef |
description | This article places its focus on methods and tools enabling the elucidation of the mechanism by which ligands, small‐molecule inhibitors, or substrates interact with zinc‐containing bacterial or human members of the histone deacetylase family (HDACs). These methods include biochemical and biophysical approaches and can be subdivided into equilibrium and kinetic methods. More information about the exact mode of action can be obtained by combining these methods with specific mutant variants of the enzymes and/or series of structural similar ligands. All available equilibrium and kinetic data including additional information from 3D structures of HDAC–ligand complexes can be beneficially combined in a data analysis procedure called Integrated Global‐Fit analysis eventually providing the most likely binding mechanism.
The understanding of the mode of action of active substances and how this is coupled to the biological response is of utmost importance for the optimization of drug candidates. This article contains a comprehensive collection of methods and protocols that enable the elucidation of the binding mechanism of inhibitors to histone deacetylases. All available equilibrium and kinetic data can be beneficially combined in a data analysis procedure called Integrated Global‐Fit analysis eventually yielding the most likely binding mechanism. |
doi_str_mv | 10.1111/cbdd.13449 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2138642095</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2138642095</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3299-82f87eb248e90d65b78dd308d1c2a86ced303901edcfd2d3628525f4663afd3</originalsourceid><addsrcrecordid>eNp9kE1PwzAMhiMEYmNw4QegHhFSR77apEfYgCFN4gD3KE1cGtQmo-mE9u_p6OCIL7blR4_kF6FLgudkqFtTWjsnjPPiCE2J4CLFVGbHf7MQE3QW4wfGnGdUnqIJw1xiJrIpWi2hh651Xvcu-CRUSV9DUjpvnX9PWjC19i62-0PtYh88JBa0gX7X6AiJ87UrXR-6eI5OKt1EuDj0GXp9fHhbrNL1y9Pz4m6dGkaLIpW0kgJKyiUU2OZZKaS1DEtLDNUyNzAsrMAErKkstSwfPqFZxfOc6cqyGboerZsufG4h9qp10UDTaA9hGxUlTOac4iIb0JsRNV2IsYNKbTrX6m6nCFb73NQ-N_WT2wBfHbzbsgX7h_4GNQBkBL5cA7t_VGpxv1yO0m-qW3gw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2138642095</pqid></control><display><type>article</type><title>Determination of the binding mechanism of histone deacetylase inhibitors</title><source>Wiley-Blackwell Journals</source><source>MEDLINE</source><creator>Meyer‐Almes, Franz‐Josef</creator><creatorcontrib>Meyer‐Almes, Franz‐Josef</creatorcontrib><description>This article places its focus on methods and tools enabling the elucidation of the mechanism by which ligands, small‐molecule inhibitors, or substrates interact with zinc‐containing bacterial or human members of the histone deacetylase family (HDACs). These methods include biochemical and biophysical approaches and can be subdivided into equilibrium and kinetic methods. More information about the exact mode of action can be obtained by combining these methods with specific mutant variants of the enzymes and/or series of structural similar ligands. All available equilibrium and kinetic data including additional information from 3D structures of HDAC–ligand complexes can be beneficially combined in a data analysis procedure called Integrated Global‐Fit analysis eventually providing the most likely binding mechanism.
The understanding of the mode of action of active substances and how this is coupled to the biological response is of utmost importance for the optimization of drug candidates. This article contains a comprehensive collection of methods and protocols that enable the elucidation of the binding mechanism of inhibitors to histone deacetylases. All available equilibrium and kinetic data can be beneficially combined in a data analysis procedure called Integrated Global‐Fit analysis eventually yielding the most likely binding mechanism.</description><identifier>ISSN: 1747-0277</identifier><identifier>EISSN: 1747-0285</identifier><identifier>DOI: 10.1111/cbdd.13449</identifier><identifier>PMID: 30480375</identifier><language>eng</language><publisher>England</publisher><subject>binding assay ; HDAC ; Histone Deacetylase Inhibitors - metabolism ; Histone Deacetylases - genetics ; Histone Deacetylases - metabolism ; Kinetics ; Ligands ; Mutation ; Protein Binding ; protein–ligand interaction ; reaction mechanism ; selective inhibitors ; thermodynamics ; Zinc - metabolism</subject><ispartof>Chemical biology & drug design, 2019-06, Vol.93 (6), p.1214-1250</ispartof><rights>2018 John Wiley & Sons A/S</rights><rights>2018 John Wiley & Sons A/S.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3299-82f87eb248e90d65b78dd308d1c2a86ced303901edcfd2d3628525f4663afd3</citedby><cites>FETCH-LOGICAL-c3299-82f87eb248e90d65b78dd308d1c2a86ced303901edcfd2d3628525f4663afd3</cites><orcidid>0000-0002-1001-3249</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fcbdd.13449$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fcbdd.13449$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30480375$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Meyer‐Almes, Franz‐Josef</creatorcontrib><title>Determination of the binding mechanism of histone deacetylase inhibitors</title><title>Chemical biology & drug design</title><addtitle>Chem Biol Drug Des</addtitle><description>This article places its focus on methods and tools enabling the elucidation of the mechanism by which ligands, small‐molecule inhibitors, or substrates interact with zinc‐containing bacterial or human members of the histone deacetylase family (HDACs). These methods include biochemical and biophysical approaches and can be subdivided into equilibrium and kinetic methods. More information about the exact mode of action can be obtained by combining these methods with specific mutant variants of the enzymes and/or series of structural similar ligands. All available equilibrium and kinetic data including additional information from 3D structures of HDAC–ligand complexes can be beneficially combined in a data analysis procedure called Integrated Global‐Fit analysis eventually providing the most likely binding mechanism.
The understanding of the mode of action of active substances and how this is coupled to the biological response is of utmost importance for the optimization of drug candidates. This article contains a comprehensive collection of methods and protocols that enable the elucidation of the binding mechanism of inhibitors to histone deacetylases. All available equilibrium and kinetic data can be beneficially combined in a data analysis procedure called Integrated Global‐Fit analysis eventually yielding the most likely binding mechanism.</description><subject>binding assay</subject><subject>HDAC</subject><subject>Histone Deacetylase Inhibitors - metabolism</subject><subject>Histone Deacetylases - genetics</subject><subject>Histone Deacetylases - metabolism</subject><subject>Kinetics</subject><subject>Ligands</subject><subject>Mutation</subject><subject>Protein Binding</subject><subject>protein–ligand interaction</subject><subject>reaction mechanism</subject><subject>selective inhibitors</subject><subject>thermodynamics</subject><subject>Zinc - metabolism</subject><issn>1747-0277</issn><issn>1747-0285</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1PwzAMhiMEYmNw4QegHhFSR77apEfYgCFN4gD3KE1cGtQmo-mE9u_p6OCIL7blR4_kF6FLgudkqFtTWjsnjPPiCE2J4CLFVGbHf7MQE3QW4wfGnGdUnqIJw1xiJrIpWi2hh651Xvcu-CRUSV9DUjpvnX9PWjC19i62-0PtYh88JBa0gX7X6AiJ87UrXR-6eI5OKt1EuDj0GXp9fHhbrNL1y9Pz4m6dGkaLIpW0kgJKyiUU2OZZKaS1DEtLDNUyNzAsrMAErKkstSwfPqFZxfOc6cqyGboerZsufG4h9qp10UDTaA9hGxUlTOac4iIb0JsRNV2IsYNKbTrX6m6nCFb73NQ-N_WT2wBfHbzbsgX7h_4GNQBkBL5cA7t_VGpxv1yO0m-qW3gw</recordid><startdate>201906</startdate><enddate>201906</enddate><creator>Meyer‐Almes, Franz‐Josef</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1001-3249</orcidid></search><sort><creationdate>201906</creationdate><title>Determination of the binding mechanism of histone deacetylase inhibitors</title><author>Meyer‐Almes, Franz‐Josef</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3299-82f87eb248e90d65b78dd308d1c2a86ced303901edcfd2d3628525f4663afd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>binding assay</topic><topic>HDAC</topic><topic>Histone Deacetylase Inhibitors - metabolism</topic><topic>Histone Deacetylases - genetics</topic><topic>Histone Deacetylases - metabolism</topic><topic>Kinetics</topic><topic>Ligands</topic><topic>Mutation</topic><topic>Protein Binding</topic><topic>protein–ligand interaction</topic><topic>reaction mechanism</topic><topic>selective inhibitors</topic><topic>thermodynamics</topic><topic>Zinc - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Meyer‐Almes, Franz‐Josef</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Chemical biology & drug design</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meyer‐Almes, Franz‐Josef</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Determination of the binding mechanism of histone deacetylase inhibitors</atitle><jtitle>Chemical biology & drug design</jtitle><addtitle>Chem Biol Drug Des</addtitle><date>2019-06</date><risdate>2019</risdate><volume>93</volume><issue>6</issue><spage>1214</spage><epage>1250</epage><pages>1214-1250</pages><issn>1747-0277</issn><eissn>1747-0285</eissn><abstract>This article places its focus on methods and tools enabling the elucidation of the mechanism by which ligands, small‐molecule inhibitors, or substrates interact with zinc‐containing bacterial or human members of the histone deacetylase family (HDACs). These methods include biochemical and biophysical approaches and can be subdivided into equilibrium and kinetic methods. More information about the exact mode of action can be obtained by combining these methods with specific mutant variants of the enzymes and/or series of structural similar ligands. All available equilibrium and kinetic data including additional information from 3D structures of HDAC–ligand complexes can be beneficially combined in a data analysis procedure called Integrated Global‐Fit analysis eventually providing the most likely binding mechanism.
The understanding of the mode of action of active substances and how this is coupled to the biological response is of utmost importance for the optimization of drug candidates. This article contains a comprehensive collection of methods and protocols that enable the elucidation of the binding mechanism of inhibitors to histone deacetylases. All available equilibrium and kinetic data can be beneficially combined in a data analysis procedure called Integrated Global‐Fit analysis eventually yielding the most likely binding mechanism.</abstract><cop>England</cop><pmid>30480375</pmid><doi>10.1111/cbdd.13449</doi><tpages>37</tpages><orcidid>https://orcid.org/0000-0002-1001-3249</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1747-0277 |
ispartof | Chemical biology & drug design, 2019-06, Vol.93 (6), p.1214-1250 |
issn | 1747-0277 1747-0285 |
language | eng |
recordid | cdi_proquest_miscellaneous_2138642095 |
source | Wiley-Blackwell Journals; MEDLINE |
subjects | binding assay HDAC Histone Deacetylase Inhibitors - metabolism Histone Deacetylases - genetics Histone Deacetylases - metabolism Kinetics Ligands Mutation Protein Binding protein–ligand interaction reaction mechanism selective inhibitors thermodynamics Zinc - metabolism |
title | Determination of the binding mechanism of histone deacetylase inhibitors |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T05%3A49%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Determination%20of%20the%20binding%20mechanism%20of%20histone%20deacetylase%20inhibitors&rft.jtitle=Chemical%20biology%20&%20drug%20design&rft.au=Meyer%E2%80%90Almes,%20Franz%E2%80%90Josef&rft.date=2019-06&rft.volume=93&rft.issue=6&rft.spage=1214&rft.epage=1250&rft.pages=1214-1250&rft.issn=1747-0277&rft.eissn=1747-0285&rft_id=info:doi/10.1111/cbdd.13449&rft_dat=%3Cproquest_cross%3E2138642095%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2138642095&rft_id=info:pmid/30480375&rfr_iscdi=true |